How did OBIO's Q3 2024 EPS surprise analysts?

Orchestra BioMed (OBIO) reported an EPS surprise of $0.02 for Q3 2024, compared to analysts' expectations. This indicates that the company's performance for the period exceeded analysts' forecasts, potentially due to factors such as strong revenue growth, cost management, or strategic initiatives.

OBIO EPS Surprise YoY, EPS Surprise